Carasent ASA

Research Carasent ASA (CARA) on Bullrun: market cap SEK 1.72B, P/E 41.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 1.72B; P/E is 41.3.

Peer valuation comparison

Latest P/E is 41.34x versus a Healthcare sector median of 24.46x (69.0% above).

Latest P/E is 41.34x versus a Sweden median of 18.57x (122.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 426.01MSEK 34.67Mn/a67.8%n/aSEK 138.03MSEK 31.94MSEK 808.00M
FY2024SEK 275.26M-SEK 42.26Mn/a84.5%-0.58SEK 263.56MSEK 41.20MSEK 892.87M
FY2023SEK 245.18M-SEK 46.67Mn/a81.1%-0.6SEK 369.09Mn/aSEK 943.15M
FY2022SEK 409.62Mn/an/a41.3%n/aSEK 737.16Mn/aSEK 1.30B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24SEK 1.72B41.3n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

YearDividends/share
FY20231.83 SEK

About Carasent ASA

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Carasent ASA's market cap?

Carasent ASA's market capitalization is SEK 1.72B.

What is Carasent ASA's P/E ratio?

Carasent ASA's price-to-earnings (P/E) ratio is 41.3.

What does Carasent ASA do?

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.